FDA Approved: LIVALO — Original Application (Kowa Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved LIVALO (pitavastatin calcium) from Kowa Pharmaceuticals America, Inc. as an original NDA (NDA022363) for the treatment of hyperlipidemia, including…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hyperlipidemia

Drugs mentioned

• LIVALO (pitavastatin calcium)

Snippet

ORIG AP for LIVALO (PITAVASTATIN CALCIUM)